Amplify Seymour Cannabis ETF (CNBS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Amplify Seymour Cannabis ETF (CNBS) trades at $27.56 with AI Score 44/100 (Grade C). Amplify Seymour Cannabis ETF (CNBS) is an actively managed ETF providing diversified exposure to the U. S. cannabis ecosystem. Market cap: $83.44M, Sector: Financial services.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for CNBS: CNBS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNBS against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CNBS: the 1 perspectives are evenly split.
How is this calculated? →Amplify Seymour Cannabis ETF (CNBS) Financial Services Profile
Amplify Seymour Cannabis ETF (CNBS) offers investors diversified exposure to the U.S. cannabis industry, encompassing plant cultivation, support services, and ancillary businesses. As an actively managed ETF, CNBS aims to achieve capital appreciation by strategically allocating investments across the cannabis value chain, distinguishing itself through its focused U.S. market approach.
What Is the Investment Thesis for CNBS?
Amplify Seymour Cannabis ETF (CNBS) presents a focused investment opportunity within the U.S. cannabis market. With a market capitalization of $83.44M and a beta of 0.18, CNBS offers exposure to a high-growth sector with relatively low volatility compared to the broader market. The primary value driver is the continued expansion and legalization of cannabis across U.S. states, creating new market opportunities for companies within the cannabis ecosystem. Upcoming catalysts include potential federal regulatory reforms and increasing consumer acceptance of cannabis products. However, potential risks include regulatory uncertainty, competition from established players, and market volatility. The ETF's active management strategy aims to capitalize on these growth opportunities while mitigating risks, making it a potentially noteworthy option for investors seeking exposure to the U.S. cannabis market.
Based on FMP financials and quantitative analysis
CNBS Key Highlights
- Market Cap: $0.08B indicates the fund's size and potential for growth within the cannabis sector.
- Beta: 0.18 suggests lower volatility compared to the broader market, potentially offering a more stable investment in a high-growth sector.
- Actively Managed: The fund's active management allows for strategic adjustments based on market conditions and regulatory changes, potentially enhancing returns.
- U.S. Focus: CNBS provides targeted exposure to the U.S. cannabis market, capitalizing on the growth potential within the evolving U.S. regulatory landscape.
- Diversified Exposure: CNBS invests across the cannabis ecosystem, encompassing companies involved in cannabis cultivation, support services, and ancillary businesses, mitigating risk through diversification.
Who Are CNBS's Competitors?
CNBS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ACSI American Customer Satisfaction ETF | $75.33 | +0.53% | $114.25M | 44 |
| BMVP Invesco Bloomberg MVP Multi-factor ETF | $51.78 | -0.27% | $100.91M | 49 |
| FLJH Franklin FTSE Japan Hedged ETF | $46.62 | +2.89% | $177.16M | 47 |
| INCE Franklin Income Equity Focus ETF | $67.64 | -0.07% | $128.29M | 50 |
| JPXN iShares JPX-Nikkei 400 ETF | $101.31 | +1.64% | $138.69M | 47 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNBS's Key Strengths?
- Diversified exposure to the U.S. cannabis market.
- Active management strategy.
- Focus on U.S.-based companies.
- Established track record.
What Are CNBS's Weaknesses?
- Relatively small market capitalization.
- Concentrated exposure to the cannabis industry.
- Dependence on regulatory developments.
- Potential for high volatility.
What Could Drive CNBS Stock Higher?
- Potential federal regulatory reforms regarding cannabis.
- Increasing legalization of cannabis at the state level.
- Expansion of cannabis-related products and services.
- Growing consumer acceptance of cannabis.
What Are the Key Risks for CNBS?
- Regulatory uncertainty and changes in cannabis laws.
- Competition from established players in the cannabis industry.
- Market volatility and fluctuations in cannabis stock prices.
- Changes in consumer preferences and demand for cannabis products.
- Dependence on regulatory developments for growth.
What Are the Growth Opportunities for CNBS?
- Increased Legalization: The ongoing legalization of cannabis at the state level in the U.S. presents a significant growth opportunity for CNBS. As more states legalize cannabis for medical or recreational use, the market size expands, creating new opportunities for companies within the cannabis ecosystem. This trend is expected to continue over the next 3-5 years, driving growth for CNBS and its underlying holdings. The total addressable market for cannabis in the U.S. is projected to reach $50 billion by 2028, providing a substantial runway for growth.
- Federal Regulatory Reform: Potential federal regulatory reforms, such as the legalization or decriminalization of cannabis at the federal level, could be a major catalyst for the cannabis industry and CNBS. Such reforms would remove significant barriers to interstate commerce and investment, opening up new opportunities for growth and expansion. While the timing of federal reforms is uncertain, the potential impact is substantial, making it a key growth driver for CNBS.
- Expansion of Cannabis-Related Products and Services: The cannabis industry is constantly evolving, with new products and services emerging to meet changing consumer demands. CNBS is positioned to benefit from this trend by investing in companies that are developing innovative cannabis-related products and services, such as edibles, beverages, and wellness products. This expansion of the cannabis ecosystem creates new revenue streams and growth opportunities for CNBS and its underlying holdings.
- Increased Consumer Acceptance: As societal attitudes towards cannabis continue to evolve, consumer acceptance is increasing, driving demand for cannabis products and services. This trend is particularly evident among younger generations, who are more likely to view cannabis favorably. CNBS is positioned to benefit from this trend by investing in companies that are catering to the growing demand for cannabis products and services among consumers. The increasing consumer acceptance of cannabis is expected to drive long-term growth for the industry and CNBS.
- Strategic Acquisitions and Partnerships: Companies within the cannabis industry are increasingly engaging in strategic acquisitions and partnerships to expand their market reach, enhance their product offerings, and gain access to new technologies. CNBS is positioned to benefit from this trend by investing in companies that are actively pursuing strategic acquisitions and partnerships. These deals can create synergies, improve efficiency, and drive growth for CNBS and its underlying holdings.
What Opportunities Does CNBS Have?
- Increased legalization of cannabis at the state and federal levels.
- Expansion of cannabis-related products and services.
- Growing consumer acceptance of cannabis.
- Strategic acquisitions and partnerships.
What Threats Does CNBS Face?
- Regulatory uncertainty.
- Competition from established players.
- Market volatility.
- Changes in consumer preferences.
What Are CNBS's Competitive Advantages?
- Diversified exposure to the U.S. cannabis market.
- Active management strategy to optimize returns.
- Focus on U.S.-based companies.
- Established track record in the cannabis ETF space.
What Does CNBS Do?
Amplify Seymour Cannabis ETF (CNBS) is an actively managed exchange-traded fund (ETF) designed to provide investors with diversified exposure to the burgeoning U.S. cannabis industry. Launched with the objective of capital appreciation, CNBS strategically invests across the cannabis ecosystem, encompassing companies involved in cannabis cultivation, support services, and ancillary businesses. The ETF's investment strategy focuses exclusively on U.S.-based companies, capitalizing on the growth potential within the evolving U.S. cannabis market. CNBS actively manages its portfolio, adapting to market dynamics and regulatory changes to optimize investment outcomes. By offering a diversified portfolio of cannabis-related companies, CNBS seeks to mitigate risk while capturing the upside potential of this rapidly expanding sector. The fund's active management approach allows for strategic adjustments based on market conditions and regulatory developments, aiming to enhance returns for investors seeking exposure to the U.S. cannabis industry. CNBS provides a vehicle for investors to participate in the growth of the U.S. cannabis market through a diversified and actively managed ETF structure.
What Products and Services Does CNBS Offer?
- Invests in U.S. companies involved in cannabis cultivation.
- Provides exposure to companies supporting the cannabis industry.
- Includes companies providing ancillary services to the cannabis sector.
- Actively manages its portfolio to optimize investment outcomes.
- Seeks capital appreciation through strategic investments.
- Offers a diversified portfolio of cannabis-related companies.
- Adapts to market dynamics and regulatory changes.
How Does CNBS Make Money?
- Generates revenue through management fees charged to investors.
- Invests in a diversified portfolio of cannabis-related companies.
- Actively manages its portfolio to maximize returns.
- Distributes capital gains to investors.
What Industry Does CNBS Operate In?
The asset management industry is undergoing significant transformation, driven by technological advancements, changing investor preferences, and increasing regulatory scrutiny. ETFs like CNBS are gaining popularity as investors seek diversified exposure to specific sectors and themes. The cannabis industry, while still nascent, is experiencing rapid growth due to increasing legalization and acceptance. CNBS is positioned to capitalize on this growth by providing investors with a convenient and diversified way to access the U.S. cannabis market. The competitive landscape includes other ETFs and investment vehicles focused on the cannabis sector, each with its own investment strategy and risk profile.
Who Are CNBS's Key Customers?
- Retail investors seeking exposure to the cannabis industry.
- Institutional investors looking for diversified cannabis investments.
- Financial advisors seeking to add cannabis exposure to client portfolios.
How Amplify Seymour Cannabis ETF Is Valued
Relative to its peer group, CNBS's quantitative score of 44/100 is roughly in line with the peer average of 47/100.
CNBS Financials
Bull Case vs Bear Case
Bull Case
- Diversified exposure to the U.S. cannabis market.
- Active management strategy.
- Focus on U.S.-based companies.
- Established track record.
Bear Case
- Relatively small market capitalization.
- Concentrated exposure to the cannabis industry.
- Dependence on regulatory developments.
- Potential for high volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CNBS Latest News
No recent news available for CNBS.
CNBS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNBS.
Price Targets
Wall Street price target analysis for CNBS.
CNBS MoonshotScore
What does this score mean?
The MoonshotScore rates CNBS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
CNBS Financial Services Stock FAQ
What does Amplify Seymour Cannabis ETF do?
Amplify Seymour Cannabis ETF (CNBS) is an actively managed exchange-traded fund (ETF) that provides investors with diversified exposure to the U.S. cannabis industry. CNBS invests in companies involved in cannabis cultivation, support services, and ancillary businesses, focusing exclusively on U.S.-based companies. The ETF aims to achieve capital appreciation by strategically allocating investments across the cannabis value chain. CNBS actively manages its portfolio, adapting to market dynamics and regulatory changes to optimize investment outcomes, making it a vehicle for investors to participate in the growth of the U.S. cannabis market.
What are the main risks for CNBS?
The main risks for CNBS include regulatory uncertainty, competition from established players, and market volatility. The cannabis industry is subject to evolving regulations at both the state and federal levels, which can impact the performance of companies within the sector. CNBS also faces competition from other ETFs and investment vehicles focused on the cannabis industry. Additionally, the cannabis market can be volatile, with stock prices subject to significant fluctuations based on news events, regulatory changes, and investor sentiment. These factors can impact the ETF's performance and returns.
How does CNBS navigate the complex regulatory landscape of the cannabis industry?
CNBS navigates the complex regulatory landscape of the cannabis industry through active management and a focus on U.S.-based companies. The ETF's investment team closely monitors regulatory developments at both the state and federal levels, adapting its investment strategy to mitigate risks and capitalize on opportunities. CNBS also invests in companies that are compliant with all applicable laws and regulations. By focusing on U.S.-based companies, CNBS avoids the complexities and uncertainties associated with international cannabis markets, which are subject to different regulatory regimes.
What is CNBS's approach to managing risk within the volatile cannabis market?
CNBS manages risk within the volatile cannabis market through diversification, active management, and a focus on U.S.-based companies. The ETF invests in a diversified portfolio of cannabis-related companies, mitigating the impact of any single company's performance on the overall portfolio. CNBS's active management strategy allows for strategic adjustments based on market conditions and regulatory changes. By focusing on U.S.-based companies, CNBS avoids the complexities and uncertainties associated with international cannabis markets, which can be more volatile and subject to different regulatory regimes. The ETF's investment team also conducts thorough due diligence on its underlying holdings to assess their financial health and risk profile.
What are the key factors to evaluate for CNBS?
Amplify Seymour Cannabis ETF (CNBS) holds an AI score of 44/100 (low). Not financial advice.
How frequently does CNBS data refresh on this page?
CNBS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CNBS's recent stock price performance?
Amplify Seymour Cannabis ETF (CNBS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified exposure to the U.S. cannabis market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CNBS overvalued or undervalued right now?
Valuing Amplify Seymour Cannabis ETF (CNBS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for CNBS.
- The cannabis industry is subject to evolving regulations and market conditions.